![]() ![]() The majority of the incremental cost-effectiveness ratios (ICERs) reported have been below the cost-effectiveness threshold suggested by the World Health Organization (WHO).Ĭonclusions: There has been an increase in the number of HEEs related to cancer in Brazil. In terms of the intended purposes of the technologies, most (63.6%) were treatments. Procedures (47.3%) were the technologies most frequently evaluated. Type of cancers most frequently studied were: breast (38.2%), cervical (14.6%), lung (10.9%) and colorectal (9.1%). Results: Fifty-five articles were reviewed, of these, 33 (60%) were full health economic evaluations. We searched multiple databases selecting partial and full HEE studies in oncology (1998-2013). Methods: A systematic review was conducted to identify and characterize studies in this field. Objective: To investigate whether the scientific literature has provided a set of HEE in oncology capable of supporting decision making in the Brazilian context. However, Brazilian HEE literature in oncology has not been studied. 4Preventive Medicine, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazilīackground: A large number of health economic evaluation (HEE) studies have been published in developed countries.3National Institute for Science and Technology for Health Technology Assessment (IATS/CNPq), Porto Alegre, Brazil.2Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil.1Department of Oncology, Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil.Decimoni 4, Roseli Leandro 4, Maria del Pilar Estevez Diz 1, Hillegonda M. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |